-
ESCAT: ESMO Scale for Clinical Actionability of molecular Targets A one-language tool for precision oncology
In 2018 ESCAT, a novel tool designed to enhance and standardize precision oncology, developed on the initiative of the ESMO Translational Research and Precision Medicine Working Group, has been presented. ESCAT employs data from massive sequencing (as next-generation sequencing analysis, NGS) to establish a hierarchy of genetic alterations in a tumor, thereby indicating those alterations that should be the primary focus of therapeutic action.
Author:Anna Lisa Bonfranceschi
Date of publication:Read more25 March 2025
-
Organoids
Organoids are three-dimensional cell cultures generated by multipotent adult stem cells or pluripotent (embryonic or induced in vitro) stem cells in the presence of an extracellular matrix that self-organize in tissue-like structures that partially reproduce features and function of the tissue of origin.
Authors:Antonio Barbáchano
,Alberto Muñoz
Date of publication:Read more23 July 2024
-
Back to the future? Temozolomide for brain tumours
Brain tumours are among the cancers with the worst outlook and are hard to treat owing to factors such as inoperable locations in the brain and the difficulty of developing drugs that can cross the blood-brain barrier.
Author:Anna Wagstaff
Date of publication:Read more17 May 2024
Coming soon
- The molecular revolution in biology and medicine
- CRISPR story
- Clonal evolution of cancer cells and Darwinian evolution
- The ‘Warburg Effect’ and Paradigm Shifts in Explaining the Cause of Cancer